CLSI MM03A2

Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline, MM03-A2

Clinical and Laboratory Standards Institute, 02/17/2006

Publisher: CLSI

File Format: PDF

$142.00$285.63

Description

Published:17/02/2006

Pages:88

This guideline addresses topics relating to clinical applications, amplified and nonamplified nucleic acid methods, selection and qualification of nucleic acid sequences, establishment and evaluation of test performance characteristics, inhibitors, and interfering substances, controlling false-positive reactions, reporting and interpretation of results, quality assurance, regulatory issues, and recommendations for manfactuers and clinical laboratories.

More CLSI standard pdf

CLSI QMS03-A4

Training and Competence Assessment; Approved Guideline--Fourth Edition; QMS03Ed4E

$90.00 $180.00

CLSI QMS21 (R2021)

Purchasing and Inventory Management, 1st Edition, QMS21Ed1E

$90.00 $180.00

CLSI I/LA20

Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E Antibodies of Defined Allergen Specificities, 3rd Edition, ILA20Ed3E

$90.00 $180.00

CLSI QMS24 (R2021)

Using Proficiency Testing and Alternative Assessment to Improve Medical Laboratory Quality, QMS24Ed3E

$90.00 $180.00